- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Partnering opportunities
- A complete cure for HBV
- A stable efficacious Toxoplasma vaccine
- Activating SMCHD1 to treat FSHD
- Improving vision outcomes in retinal detachment
- Intercepting inflammation with RIPK2 inhibitors
- Novel inhibitors for the treatment of lupus
- Novel malaria vaccine
- Precision epigenetics silencing SMCHD1 to treat Prader Willi Syndrome
- Rethinking CD52 a therapy for autoimmune disease
- Targeting minor class splicing
- Royalties distribution
- Start-up companies
- Partnering opportunities
- Collaborators
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- People
- Anne-Laure Puaux
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Emma Josefsson
- Associate Professor Ethan Goddard-Borger
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Murphy
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Leanne Robinson
- Associate Professor Marco Herold Marco Herold
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Sant-Rayn Pasricha
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Wai-Hong Tham
- Associate Professor Wei Shi
- Catherine Parker
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gemma Kelly
- Dr Gwo Yaw Ho
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Joanna Groom
- Dr John Wentworth
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Melissa Call
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Samir Taoudi
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Simon Chatfield
- Dr Tracy Putoczki
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Joel Chibert
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Gabrielle Belz
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Burgess
- Professor Tony Papenfuss
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Undergraduate
- Student research projects
- A new regulator of stemness to create dendritic cell factories for immunotherapy
- Advanced methods for genomic rearrangement detection
- Control of cytokine signaling by SOCS1
- Defining the protein modifications associated with respiratory disease
- Delineating the pathways driving cancer development and therapy resistance
- Developing a new drug that targets plasmacytoid dendritic cells for the treatment of lupus
- Development and mechanism of action of novel antimalarials
- Development of a novel particle-based malaria vaccine
- Development of tau-specific therapeutic and diagnostic antibodies
- Discovering novel therapies for major human pathogens
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Epigenetic biomarkers of tuberculosis infection
- Essential role of glycobiology in malaria parasites
- Evolution of haematopoiesis in vertebrates
- Human lung protective immunity to tuberculosis
- Identifying novel treatment options for ovarian carcinosarcoma
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of mutant p53 in cancer
- Microbiome strain-level analysis using long read sequencing
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Modelling spatial and demographic heterogeneity of malaria transmission risk
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Structural basis of catenin-independent Wnt signalling
- Structure and biology of proteins essential for Toxoplasma parasite invasion
- T lymphocytes: how memories are made
- TICKER: A cell history recorder for longitudinal patient monitoring
- Targeting host pathways to develop new broad-spectrum antiviral drugs
- Targeting post-translational modifications to disrupting the function of secreted proteins
- Targeting the epigenome to rewire pro-allergic T cells
- Targeting the immune microenvironment to treat KRAS-mutant adenocarcinoma
- The E3 ubiquitin ligase Parkin and mitophagy in Parkinson’s disease
- The molecular controls on dendritic cell development
- Understanding malaria infection dynamics
- Understanding the genetics of neutrophil maturation
- Understanding the neuroimmune regulation of innate immunity
- Understanding the proteins that regulate programmed cell death at the molecular level
- Using cutting-edge single cell tools to understand the origins of cancer
- When healthy cells turn bad: how immune responses can transition to lymphoma
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Giardiasis

Giardiasis is a parasitic disease causing chronic diarrhoea. It disproportionately affects young children - it can exacerbate malnutrition and lead to significant delays in physical and cognitive development.
There are more than 280 million cases of giardiasis worldwide each year, but treatment is limited to a small number of drugs and drug resistance is emerging.
Our researchers are using advanced genome technologies to explore parasite biology, with the goal of developing approaches to understand drug resistance and better control the disease.
Giardiasis research at WEHI
Our researchers are:
- Using advanced sequencing technologies to understand how parasites develop and interact with their host.
- Studying how parasites develop resistance to common drugs.
- Evaluating the impact of giardiasis on childhood health and development.
- Working with the Victorian water industry to develop tools for monitoring parasites in the water supply.
- Investigating parasite epidemiology in developed and resource-poor communities.
What is giardiasis?
Giardiasis is a diarrhoeal disease caused by the parasite Giardia duodenalis.
Giardia is a tiny, single-celled organism with multiple whip-like tails, called flagella. The parasite lives in the small intestine of mammals - including humans - where it interferes with the absorption of nutrients from food. As the parasite travels down the digestive tract, it develops into cysts that are shed in faeces. The cysts can survive in the environment for weeks or months.
The Giardia parasite is transmitted when people swallow cysts via hand-to-mouth contact. For example, outbreaks are common in childcare centres due to poor hand hygiene after changing nappies.
Transmission can also occur through contaminated water supplies: the parasite is spread when people drink the water, use it to wash their food or ingest it during recreational activities such as swimming. This is a common route of infection for travellers and people hiking or camping in the wilderness.
There are up to 600,000 cases of giardiasis in Australia each year, and more than 280 million cases worldwide. The disease has a disproportionately high impact on children in impoverished communities, including in remote Indigenous communities in Australia.
Symptoms of giardiasis
Symptoms of giardiasis usually develop one to three weeks following infection and can include:
- Diarrhoea and greasy stools that float
- Nausea/vomiting
- Gas
- Abdominal cramps
- Dehydration
- Post-infectious irritable bowel syndrome
- Chronic giardiasis can lead to significant long-term effects including malnutrition, weight loss, delayed physical and mental growth and predisposition to other diseases.
Some people with giardiasis show no symptoms but can still transmit the disease.
Risk factors for giardiasis
People at risk of giardiasis include:
- Children and staff at childcare centres
- Family members of people with giardiasis
- Travellers to areas where giardiasis is common
- Hikers or campers who drink untreated water from lakes and rivers
- People who swim in contaminated water, such as lakes, rivers and swimming pools
- Practising good hygiene and avoiding contaminated food and water when travelling reduces the risk of giardiasis
How is giardiasis treated?
Many cases of giardiasis are self-limiting and resolve on their own. Other cases are more persistent and require treatment to clear the infection.
The drugs currently available to treat giardiasis have significant side effects and are not always effective; drug resistance is emerging, leading to treatment failure. Chronic giardiasis remains a major health and economic burden, particularly in resource-poor communities. These limitations highlight the need for new drugs to treat giardiasis.
Applying genome technologies
Our researchers are using advanced genome technologies to study the Giardia parasite. The parasite has a compact genome and can be readily grown in the lab, making it possible to investigate genes that regulate fundamental aspects of parasite biology, including:
- Invasion of and development within the host
- Development, transmission and detection of drug resistance
- Identification of novel targets for new drug development
These genomic tools can also be used to explore how the parasites develop resistance to common drugs.
Ultimately, understanding the genes that control key aspects of parasite biology will underpin approaches to detect, treat and control giardiasis.
this structure to understand how the parasite survives in its human host.
Credit: Brendan Ansell, Balu Balan, Aaron Jex
Researchers:
Super Content:
A research fellowship has been established to improve the identification and control of water-borne illness.
The Pierce Armstrong Foundation has funded a 'cool' new piece of equipment for studies aiming to combat drug resistance in treating Giardia.
Dr Samantha Emery has won a two-year grant from The Jack Brockhoff Foundation to support her studies in the parasite, Giardia duodenalis.